Document is current
Any future updates will be listed below
-
Authors
Jang, Yoonjeong
Kim, Yoon-Sang
Wielgosz, Matthew M.
Ferrara, Francesca http://orcid.org/0000-0002-4973-1520
Ma, Zhijun
Condori, Jose
Palmer, Lance E.
Zhao, Xiwen http://orcid.org/0000-0001-5678-8843
Kang, Guolian
Rawlings, David J.
Zhou, Sheng
Ryu, Byoung Y.
-
Funding
Funding for this research was provided by:
Assisi Foundation of Memphis (94-000 R18, 94-000 R18, 94-000 R18, 94-000 R18, 94-000 R18)
St. Jude Children's Research Hospital Research Consortium "Novel Gene Therapies for Sickle Cell Disease"
St. Jude Children's Research Hospital Research Consortium "Novel Gene Therapies for Sickle Cell Disease"
St. Jude Children's Research Hospital Research Consortium "Novel Gene Therapies for Sickle Cell Disease"
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (P01 HL053749, P01 HL053749, P01 HL053749)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
St. Jude Children's Research Hospital Research Consortium "Novel Gene Therapies for Sickle Cell Disease"
- License Information
-
More Information
Article History
Received: 30 October 2019
Revised: 1 April 2020
Accepted: 3 April 2020
First Online: 27 April 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
